Equity indices drop amid trade tensions, awaiting RBI policy decision; markets brace for heightened volatility post-tariff ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial, ...

Beauty takes a bold turn this S/S25 season. Discover the trends that dominated the runways, with tips, tricks and product ...

Forget the temperature – for hayfever sufferers the pollen count is also a key metric that can turn what otherwise looks like a beautiful day for riding into a nightmare no-go. Hayfever season lasts ...

Beneficiary – I am Gopikrishnan, Entrepreneur based of Mudra loan from Kerala. Pradhan Mantri Mudra Yojana has transformed me ...

Ophthalmologists and occupational therapist can advise you on the best method to manage vision changes, including therapy to compensate for vision loss, prism lenses, sunglasses, an eye patch, or eye ...

All these firms recorded higher growth rates compared to Indian Pharma Market. Among other outperformers were Sun Pharmaceutical Industries and Glenmark Pharmaceuticals. Sun Pharmaceuticals marked ...

NEW DELHI: Drug makers Glenmark, Sun Pharma and Zydus are recalling products in the US for manufacturing issues, the US Food and Drug Administration (USFDA) said in its latest Enforcement Report.

taking its three-day cumulative drop to 3%. Among individual performers, J B Chemicals & Pharmaceuticals shares emerged as the top laggards, dropping 6%. Ajanta Pharma, Granules India, and Sun ...

Folk music icon Art Garfunkel is returning to the public eye by participating in a psoriasis awareness ... is speaking out for the first time about living with psoriasis in Sun Pharma’s I LUV YA for ...

Sun Pharma has invested in the company. Sun has cited 'insufficent funding' as the reason behind this drop. In its statement, the company said, "This is to inform you that the Company has received ...

After a legal decision delayed its entry last fall, Sun Pharma has received the all-clear to tap into the U.S. alopecia market with its JAK inhibitor Leqselvi, teeing up a potential showdown with ...